Preclinical study reveals that immune cells in the brain could be possible new drug targets for ASD and intellectual disability BUFFALO, N.Y. — University at Buffalo scientists have discovered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback